Research Blog

VUMC joins Human Vaccine Project as first scientific hub

Vanderbilt University Medical Center (VUMC), the Human Vaccines Project and the International AIDS Vaccine Initiative (IAVI) announced this week that VUMC has become the project’s first scientific hub.

Grant enhances mental illness drug research efforts

Research at Vanderbilt University Medical Center aimed at developing potential new treatments for major depressive disorder, general anxiety disorder and post-traumatic stress disorder got a big boost this week from The William K. Warren Foundation of Tulsa, Oklahoma.

VUMC lands major pharmacogenomics grant

Vanderbilt University Medical Center has received a five-year, $12.8 million grant from the federal government to develop better ways to predict how patients will respond to the drugs they’re given.

Gates grant bolsters study of Tdap boosters in pregnant women

Kathryn Edwards, M.D., director of the Vanderbilt Vaccine Research Program, has received a $307,000 grant from the Bill & Melinda Gates Foundation to study the immune responses of pregnant women who receive the Tdap (reduced-dose acellular pertussis vaccines combined with tetanus and diphtheria toxoids) vaccine.

Phyllis Freeman Randy Blakely Vanderbilt Lab

NSF award goes to Fisk geneticist following VU post-doc training

The partnership with Fisk through the Fisk-Vanderbilt Masters-to-PhD Bridge Program and other avenues, “presents us with an opportunity to see the results of our efforts impact an under-served community.”

VUMC’s Patrick speaks to members of congress about neonatal abstinence syndrome

Stephen Patrick, M.D., MPH, assistant professor of Pediatrics and Health Policy in the Division of Neonatology with the Monroe Carell Jr. Children’s Hospital at Vanderbilt, recently testified before congress about the rise in neonatal abstinence syndrome.

1 7 8 9 10 11 17